RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value: $722M (100.0% shares, 0.0% debt)

Holdings (32)

WVE WAVE LIFE SCIENCES LTD 20.3%
Value $147M Shares 7,088,651 Share Price $20.69 * Est. Cost/Share $15.68 Unrealized @ Report Date -0.7%
— ACHILLION PHARMACEUTICALS INC 13.0%
Value $93.86M Shares 12,033,220 Share Price $7.80 Est. Cost/Share $6.45 Unrealized @ Report Date —
— AXOVANT SCIENCES LTD 8.9%
Value $64.2M Shares 5,000,000 Share Price $12.84 Est. Cost/Share $20.38 Unrealized @ Report Date —
— AVEXIS INC 7.1%
Value $50.92M Shares 1,339,382 Share Price $38.02 Est. Cost/Share $27.24 Unrealized @ Report Date —
ACRS ACLARIS THERAPEUTICS INC 6.7%
Value $48.53M Shares 2,627,719 Share Price $18.47 * Est. Cost/Share $19.34 Unrealized @ Report Date +2.5%
— NEKTAR THERAPEUTICS 6.4%
Value $45.89M Shares 3,224,854 Share Price $14.23 Est. Cost/Share $13.76 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 6.3%
Value $45.29M Shares 3,412,857 Share Price $13.27 Est. Cost/Share $16.15 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 3.8%
Value $27.46M Shares 4,531,714 Share Price $6.06 * Est. Cost/Share $10.14 Unrealized @ Report Date -19.8%
ARDX ARDELYX INC 2.8%
Value $20.19M Shares 2,312,243 Share Price $8.73 * Est. Cost/Share $10.53 Unrealized @ Report Date -22.4%
— ZOGENIX INC 2.7%
Value $19.73M Shares 2,451,237 Share Price $8.05 Est. Cost/Share $13.45 Unrealized @ Report Date —
— VITAE PHARMACEUTICALS INC 2.4%
Value $16.99M Shares 1,575,000 Share Price $10.79 Est. Cost/Share $7.52 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 1.9%
Value $13.99M Shares 1,292,940 Share Price $10.82 Est. Cost/Share $20.75 Unrealized @ Report Date —
— ALCOBRA LTD 1.9%
Value $13.62M Shares 3,032,911 Share Price $4.49 Est. Cost/Share $6.39 Unrealized @ Report Date —
— PROTEON THERAPEUTICS INC 1.8%
Value $13.06M Shares 1,626,931 Share Price $8.03 Est. Cost/Share $11.31 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 1.6%
Value $11.2M Shares 1,691,977 Share Price $6.62 Est. Cost/Share $13.76 Unrealized @ Report Date —
— STRONGBRIDGE BIOPHARMA PLC 1.5%
Value $10.65M Shares 2,675,338 Share Price $3.98 Est. Cost/Share $7.60 Unrealized @ Report Date —
NTRA NATERA INC 1.3%
Value $9.453M Shares 783,520 Share Price $12.06 * Est. Cost/Share $16.90 Unrealized @ Report Date -34.2%
— DIMENSION THERAPEUTICS INC 1.3%
Value $9.288M Shares 1,548,033 Share Price $6.00 Est. Cost/Share $10.25 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 1.2%
Value $8.491M Shares 2,989,795 Share Price $2.84 * Est. Cost/Share $9.58 Unrealized @ Report Date -67.6%
— DICERNA PHARMACEUTICALS INC 1.0%
Value $7.286M Shares 2,428,571 Share Price $3.00 Est. Cost/Share $28.25 Unrealized @ Report Date —
SGMO SANGAMO BIOSCIENCES INC 0.9%
Value $6.751M Shares 1,165,938 Share Price $5.79 * Est. Cost/Share $8.61 Unrealized @ Report Date -26.0%
— AGILE THERAPEUTICS INC 0.9%
Value $6.492M Shares 853,151 Share Price $7.61 Est. Cost/Share $6.21 Unrealized @ Report Date —
— TENAX THERAPEUTICS INC 0.8%
Value $6.118M Shares 2,389,700 Share Price $2.56 Est. Cost/Share $3.92 Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 0.8%
Value $5.781M Shares 291,700 Share Price $19.82 Est. Cost/Share $16.77 Unrealized @ Report Date —
ONC BEIGENE LTD 0.7%
Value $5.066M Shares 170,000 Share Price $29.80 Est. Cost/Share $29.31 Unrealized @ Report Date —
— CIDARA THERAPEUTICS INC 0.6%
Value $4.235M Shares 410,809 Share Price $10.31 Est. Cost/Share $13.98 Unrealized @ Report Date —
— AKARI THERAPEUTICS PLC 0.4%
Value $3.16M Shares 234,240 Share Price $13.49 Est. Cost/Share $24.00 Unrealized @ Report Date —
— AEGLEA BIOTHERAPEUTICS INC 0.4%
Value $2.535M Shares 521,550 Share Price $4.86 Est. Cost/Share $4.86 Unrealized @ Report Date —
— MERUS N V 0.3%
Value $1.898M Shares 237,599 Share Price $7.99 Est. Cost/Share $7.99 Unrealized @ Report Date —
— ZYNERBA PHARMACEUTICALS INC 0.2%
Value $1.736M Shares 253,468 Share Price $6.85 Est. Cost/Share $14.31 Unrealized @ Report Date —
— ARCA BIOPHARMA INC 0.2%
Value $1.632M Shares 562,693 Share Price $2.90 Est. Cost/Share $4.96 Unrealized @ Report Date —
— PRONAI THERAPEUTICS INC 0.0%
Value $59,000 Shares 29,719 Share Price $1.99 Est. Cost/Share $20.52 Unrealized @ Report Date —